Oncology

News

NHS England pushes BRCA testing for Jewish community

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer.

News

Jazz buys KRAS inhibitors from Redx in $880m deal

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma,

News

GSK backs up its Blenrep rehab bid with survival data

GSK has revealed the data it hopes will allow a return to the US market for Blenrep, which was the first BCMA-targeting drug to launch there, but was withdrawn from sale after it fail

News

Pfizer partners American Cancer Society on health equity

A new $15 million initiative between Pfizer and the American Cancer Society (ACS) aims to tackle one of the most pressing issues in health at the moment – unequal access t

News

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

Novartis is continuing a streak of pipeline-building deals with an agreement to buy Germany’s MorphoSys in a transaction that values the cancer-focused biotech at €2.7 billion (around

News

Metagenomi prices IPO and NeOnc joins list of hopefuls

Gene editing start-up Metagenomi and cancer specialist NeOnc Technologies have announced the terms of their initial public offerings, in another sign that investor interes

NHS England pushes BRCA testing for Jewish community

Jazz buys KRAS inhibitors from Redx in $880m deal

GSK backs up its Blenrep rehab bid with survival data

Pfizer partners American Cancer Society on health equity

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

Metagenomi prices IPO and NeOnc joins list of hopefuls

ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o...

Discover a new era of healthcare panel engagement: Grounded ...

Oncology

Editor's Picks